Hollow mesoporous silicas as a drug solution delivery system for insoluble drugs

Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs)

Antimicrobial peptides (AMPs) can be used as alternative therapeutic agents to traditional antibiotics. These peptides have abundant natural template sources and can be isolated from animals, plants, and microorganisms. They are amphiphilic and mostly net positively charged, and they have a broad-spectrum inhibitory effect on bacteria, fungi, and viruses. AMPs possess significant rapid killing effects and do not interact with specific receptors on bacterial surfaces. As a result, drug resistance is rarely observed with treatments. AMPs, however, have some operational problems, such as a susceptibility to enzymatic (protease) degradation, toxicity in vivo, and unclear pharmacokinetics. However, nanodelivery systems loaded with AMPs provide a safe mechanism of packaging such peptides before they exert their antimicrobial actions, facilitate targeted delivery to the sites of infection, and control the release rate of peptides and reduce their toxic side effects. However, nanodelivery systems using AMPs are at an early stage of development and are still in the laboratory phase of development. There are also some challenges in incorporating AMPs into nanodelivery systems. Herein, an insight into the nanotechnology challenges in delivering AMPs, current advances, and remaining technological challenges are discussed in depth.

Synthesis of Colloidal Mesoporous Silica Spheres with Large Through-Holes on the Shell

Colloidal silica spheres with controllable large through-holes and mesopores on the shell were synthesized by using polystyrene (PS) spheres as a hard template and cationic surfactant hexadecyl trimethylammonium bromide (CTAB) as a soft template. Through modulating the synthetic conditions, including the volume ratio of ethanol (EtOH)/water, the amount of ammonia hydroxide, and the dosage of CTAB, SiO₂ spheres can transform among hollow structure, through-hole structure, and no large pore structure. The investigation suggests that the hydrolysis rate of the silica source and the interaction strength between the PS sphere template and SiO₂ may determine the large pore structure of the final product. The moderate hydrolysis rate of tetraethyl orthosilicate (TEOS) and strong interaction between the PS sphere template and SiO₂ is conductive to the formation of large through-holes in SiO₂ spheres. To further investigate the pore structure of through-holes of SiO₂ spheres, the lysozyme (Lz) was selected as a model molecule for adsorption experiments. The Lz adsorption experiments show that SiO₂ spheres with through-hole structure exhibit a much faster adsorption rate than SiO₂ spheres with hollow structure and higher adsorption capacity than SiO₂ with no large pore structure. Such a behavior could find interesting applications in the fields that require a fast-loading characteristic.

Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents

Hollow mesoporous silica microsphere (HMSM) particles are one of the most promising vehicles for efficient drug delivery owing to their large hollow interior cavity for drug loading and the permeable mesoporous shell for controlled drug release. Here, we report an easily controllable aerosol-based approach to produce HMSM particles by continuous spray-drying of colloidal silica nanoparticles and Eudragit/Triton X100 composite (EUT) nanospheres as templates, followed by template removal. Importantly, the internal structure of the hollow cavity and the external morphology and the porosity of the mesoporous shell can be tuned to a certain extent by adjusting the experimental conditions (i.e., silica to EUT mass ratio and particle size of silica nanoparticles) to optimize the drug loading capacity and the controlled-release properties. Then, the application of aerosol-synthesized HMSM particles in controlled drug delivery was investigated by loading amoxicillin as an antibiotic compound with high entrapment efficiency (up to 46%). Furthermore, to improve the biocompatibility of the amoxicillin-loaded HMSM particles, their surfaces were functionalized with poly(allylamine hydrochloride) and alginate as biocompatible polymers via the layer-by-layer assembly. The resulting particles were evaluated toward Escherichia coli (Gram-negative) bacteria and indicated the bacterial inhibition up to 90% in less than 2 h. Finally, we explored the versatility of HMSMs as drug carriers for pancreatic cancer treatment. Because the pH value of the extracellular medium in pancreatic tumors is lower than that of the healthy tissue, chitosan as a pH-sensitive gatekeeper was grafted to the HMSM surface and then loaded with a pro-apoptotic NCL antagonist agent (N6L) as an anticancer drug. The obtained particles exhibited pH-responsive drug releases and excellent anticancer activities with inhibition of cancer cell growth up to 60%.

Adsorption of the methyl green dye pollutant from aqueous solution using mesoporous materials MCM-41 in a fixed-bed column

In this study, a Methyl Green (MG) dye pollutant was separated by Mobil Composition Matter No. 41 (MCM-41) in a fixed-bed continuous column with investigated three parameters, namely a bed height (2-6 cm), initial MG concentration (10-30 mgL^-1) and a process flow rate (0.8-1.6 mL min^-1). Results indicated that the highest bed capacity of 20.97 mg/g was obtained with respective to optimal values such as; 6 cm for a column height, 0.8 mL min^-1 for flow rate, and an initial MG concentration 20 mgL^-1. Furthermore, a quantity of the adsorbed pollutant decreased as the flow rate increased, while increasing the initial MG concentration yielded the opposite effect. The column apparatus was performed properly at the low flow rate, whereas both the breakthrough and exhaustion time increased with the bed depth. Thomas and Yoon-Nelson models were applied for predicting the breakthrough curves and calculating the characteristic factors of the laboratory fixed-bed adsorption column, which were beneficial for process design. Based on regression coefficient analyses, results of employing the Yoon-Nelson model was found to be superior to the Thomas one. Breakthrough performance indicated that MCM-41 was suitable for applications in continuous adsorption regimes for MG dye. The mesoporous MCM-41 was recovered effectively by calcinations and employed again for four times in the continuous system successfully.

Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin

The aim of this work is to develop curcumin-loaded hollow mesoporous silica microspheres (HMSMs@curcumin) to improve the poor oral bioavailability of curcumin. Hollow mesoporous silica microspheres (HMSMs) were synthesized in facile route using a hard template. HMSMs and HMSMs@curcumin were characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), nitrogen adsorption/desorption measurements, differential scanning calorimetry (DSC), Fourier transform infrared (FTIR), and X-ray diffraction (XRD). In addition, to demonstrate the potential application of the HMSMs@curcumin, cytotoxicity, in vitro release behavior and in vivo pharmacokinetics of curcumin loaded in these HMSMs were investigated by using of Caco-2 cells and Sprague-Dawley (SD) rats, respectively. These mono-dispersed HMSMs exhibited high drug loading ratio and encapsulation efficiency due to the mesoporous shell and hollow core. The excellent characteristics of HMSMs such as mono-dispersed morphology, smooth surface, uniform, ordered and size-narrowing mesopores resulted in a good in vitro release profile of curcumin from HMSMs@curcumin. Moreover, an impressive improvement in the oral absorption of curcumin and prolonged systemic circulation time were achieved in the in vivo animal studies. In addition, the good biocompatibility of developed HMSMs with Caco-2 cells was confirmed based on the in vitro cytotoxicity assay. In conclusion, this system demonstrated a great potential for efficient delivery of curcumin in vitro and in vivo, suggesting a good prospect for its application in clinic for therapeutic drug delivery in future.

Liquisolid technique and its applications in pharmaceutics

Most of the newly developed drug candidates are lipophilic and poorly water-soluble. Enhancing the dissolution and bioavailability of these drugs is a major challenge for the pharmaceutical industry. Liquisolid technique, which is based on the conversion of the drug in liquid state into an apparently dry, non-adherent, free flowing and compressible powder, is a novel and advanced approach to tackle the issue. The objective of this article is to present an overview of liquisolid technique and summarize the progress of its applications in pharmaceutics. Low cost, simple processing and great potentials in industrial production are main advantages of this approach. In addition to the enhancement of dissolution rate of poorly water-soluble drugs, this technique is also a fairly new technique to effectively retard drug release. Furthermore, liquisolid technique has been investigated as a tool to minimize the effect of pH variation on drug release and as a promising alternative to conventional coating for the improvement of drug photostability in solid dosage forms. Overall, liquisolid technique is a newly developed and promising tool for enhancing drug dissolution and sustaining drug release, and its potential applications in pharmaceutics are still being broadened.